Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine
- PMID: 2015173
- PMCID: PMC1368414
- DOI: 10.1111/j.1365-2125.1991.tb03859.x
Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine
Abstract
1. Almitrine bismesylate displays wide inter-subject variation in peak plasma concentrations and can induce peripheral polyneuropathy. 2. The phenotyped volunteer panel approach was used to examine whether almitrine oxidation displayed a genetic polymorphism of the debrisoquine/sparteine type. 3. There was no difference between poor and extensive metabolisers of debrisoquine with respect to the pharmacokinetics and metabolism of almitrine.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources